ALK-Abello A/S (AKBLF)
37.92
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
ALK-Abello Total Liabilities (Quarterly) : 425.67M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 425.67M |
| March 31, 2026 | 419.56M |
| December 31, 2025 | 428.80M |
| September 30, 2025 | 362.20M |
| June 30, 2025 | 381.54M |
| March 31, 2025 | 363.70M |
| December 31, 2024 | 487.67M |
| September 30, 2024 | 308.86M |
| June 30, 2024 | 305.54M |
| March 31, 2024 | 303.19M |
| December 31, 2023 | 434.77M |
| September 30, 2023 | 316.19M |
| June 30, 2023 | 333.05M |
| March 31, 2023 | 326.40M |
| December 31, 2022 | 435.14M |
| September 30, 2022 | 307.51M |
| June 30, 2022 | 340.35M |
| March 31, 2022 | 345.68M |
| December 31, 2021 | 479.95M |
| September 30, 2021 | 374.68M |
| June 30, 2021 | 370.94M |
| March 31, 2021 | 389.07M |
| December 31, 2020 | 396.15M |
| September 30, 2020 | 373.36M |
| June 30, 2020 | 367.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 347.02M |
| December 31, 2019 | 348.36M |
| September 30, 2019 | 277.14M |
| June 30, 2019 | 297.07M |
| March 31, 2019 | 291.34M |
| December 31, 2018 | 258.27M |
| September 30, 2018 | 244.85M |
| June 30, 2018 | 256.84M |
| March 31, 2018 | 269.76M |
| December 31, 2017 | 269.01M |
| September 30, 2017 | 277.05M |
| June 30, 2017 | 275.66M |
| March 31, 2017 | 287.66M |
| December 31, 2016 | 272.93M |
| September 30, 2016 | 254.60M |
| June 30, 2016 | 248.03M |
| March 31, 2016 | 254.06M |
| December 31, 2015 | 226.35M |
| September 30, 2015 | 219.65M |
| June 30, 2015 | 212.69M |
| March 31, 2015 | 162.59M |
| December 31, 2014 | 173.07M |
| September 30, 2014 | 172.93M |
| June 30, 2014 | 187.32M |
| March 31, 2014 | 194.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk A/S | 57.15B |
| H. Lundbeck A/S | 3.952B |
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Shareholders Equity (Quarterly) | 1.062B |
| Debt to Equity Ratio | 0.0608 |
| Current Ratio | 3.457 |
| Net Debt Paydown Yield | 0.11% |